Clinical Trial Update: Reduction of Myopotential Interference With Smart Pass in S-ICD Patients [NA]

View source ↗

Summary

A clinical trial evaluating whether the Smart Pass feature reduces myopotential interference in patients with subcutaneous ICDs is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Ventricular Tachyarrhythmia

Snippet

Sponsor: Medical University of South Carolina | Conditions: Subcutaneous ICD, Myopotential Interference | NA | Status: RECRUITING